AbbVie Reports Third-Quarter 2026 Financial Results
Revenue$17.404 billion+10.3% YoY
EPS$2.37
Outlookraisedguidance
Revenue
—
not detected
EPS
—
not detected
Guidance
issuedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
What the company states
Guidance
Guidance issued
…Previously announced guidance excluding Q3 2026 acquired IPR&D and milestones expense.…
Other releases from AbbVie Inc.
All →
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.